Journal of Electrocardiology
Volume 43, Issue 5 , Pages 379-384, September 2010

New York Heart Association Functional class influences the impact of diabetes on cardiac autonomic function

  • Phyllis K. Stein, PhD

      Affiliations

    • Washington University School of Medicine, St. Louis, MO, USA
    • Corresponding Author InformationCorresponding author. Washington University School of Medicine HRV Lab, 4625 Lindell Blvd, Suite 402, St. Louis, MO 63108, USA.
  • ,
  • Prakash Deedwania, MD

      Affiliations

    • UCSF Fresno/VACCHS, Fresno, CA, USA

Received 28 May 2008 published online 25 January 2010.

Abstract 

Background

Diabetes (D) and heart failure (HF) are associated with abnormal heart rate variability (HRV). It is unclear whether the HRV effect of having both is cumulative.

Methods

Pretreatment HRV (traditional, nonlinear, and heart rate [HR] turbulence) in 80 D versus 74 non-D (ND) systolic HF patients was compared by New York Heart Association II versus III among patients entered into an HF drug evaluation study.

Results

Age-adjusted HR was lower in class II D versus class III and most HRV including HR turbulence was better in class II ND versus all others, with few differences between class II D and class III ND and D patients.

Conclusion

The effect of D and HF on autonomic function may be cumulative in class II, but D may have little additional effect on most HRV in class III patients. The prognostic value of different HRV measures in D versus ND HF patients should be further investigated.

Keywords: Diabetes, Heart Failure, NYHA classification, Heart rate variability, Ambulatory ECG monitoring, Heart rate turbulence

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Study supported by Takeda Pharmaceuticals North America.

PII: S0022-0736(09)00627-X

doi:10.1016/j.jelectrocard.2009.12.008

Journal of Electrocardiology
Volume 43, Issue 5 , Pages 379-384, September 2010